2区TEVAR中左锁骨下动脉血运重建:开放与腔内方式的比较结局
基于SVS VQI TEVAR登记库2013—2026年723例非创伤性2区TEVAR伴左锁骨下动脉血运重建患者,比较颈动脉-锁骨下动脉旁路(CSB)+TEVAR、分支型TEVAR与开窗型TEVAR的围手术期及随访结局。各组院内死亡、脑血管事件、卒中和脊髓缺血无显著差异;CSB+TEVAR出血更多、手术时间更长、分期治疗更常见、技术成功率更低、术后住院更长。校正后多数结局无显著差异,支持按解剖、器械可及性和机构经验个体化选择。
要点
- CSB+TEVAR围手术期负担更重:出血多、手术时间长、技术成功率低、住院更长。
- 各组院内死亡、卒中、脑血管事件及脊髓缺血均无显著差异。
- 校正后分支型TEVAR出院前主动脉再干预 odds 更低、术后住院更短。
核心结论
- CSB+TEVAR、分支型TEVAR与开窗型TEVAR在2区TEVAR中呈现不同的手术特征。
- 校正后多数围手术期与随访结局无显著差异,支持个体化选择左锁骨下动脉血运重建策略。
研究设计与样本
- 回顾性队列研究,查询SVS VQI TEVAR登记库2013至2026年数据。
- 纳入723例来自113个中心的非创伤性2区TEVAR伴左锁骨下动脉血运重建患者。
- 采用omnibus检验、全队列多变量校正回归,并进行配对倾向评分匹配敏感性分析。
主要发现
- 406例(56.2%)接受CSB+TEVAR,205例(28.4%)分支型TEVAR,112例(15.5%)开窗型TEVAR。
- 院内死亡3.2% vs 1.0% vs 3.6%(P = .212),脑血管事件6.4% vs 3.4% vs 5.4%(P = .303)。
- 卒中5.9% vs 2.9% vs 5.4%(P = .272),脊髓缺血3.0% vs 4.9% vs 0.9%(P = .143)。
- CSB+TEVAR出血更多、手术时间更长、分期治疗更常见、技术成功率更低、术后住院更长。
关键数值与推荐
- 全队列多变量校正后,分支型TEVAR较CSB+TEVAR出院前主动脉再干预校正 odds 更低、术后住院更短。
- log-rank检验示总生存与免于主动脉再干预无显著差异,免于瘤囊增大有显著差异。
- 配对倾向评分匹配分析中多数围手术期结局无显著差异,但匹配样本量有限。
临床怎么用
- 左锁骨下动脉血运重建方式应结合解剖条件、器械可及性与机构经验个体化选择。
- 重视CSB+TEVAR围手术期负担较重,包括出血、手术时间与住院时长。
局限性
- 为登记库回顾性研究,配对倾向评分匹配样本量有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare perioperative and follow-up outcomes of carotid-subclavian bypass (CSB)+thoracic endovascular aortic repair (TEVAR), branched TEVAR, and fenestrated TEVAR for left subclavian artery revascularization during zone 2 TEVAR. METHODS: The Society for Vascular Surgery Vascular Quality Initiative TEVAR registry was queried from 2013 to 2026 to identify nontraumatic zone 2 TEVAR procedures with left subclavian artery revascularization. The outcomes were compared using omnibus testing and full-cohort multivariable-adjusted regression, with pairwise propensity score-matched sensitivity analysis also performed. RESULTS: Among 723 patients from 113 centers, 406 (56.2%) underwent CSB+TEVAR, 205 (28.4%) underwent branched TEVAR, and 112 (15.5%) underwent fenestrated TEVAR. In-hospital mortality (3.2% vs 1.0% vs 3.6%; P = .212), cerebrovascular events (6.4% vs 3.4% vs 5.4%; P = .303), stroke (5.9% vs 2.9% vs 5.4%; P = .272), and spinal cord ischemia (3.0% vs 4.9% vs 0.9%; P = .143) did not differ significantly among the groups. CSB+TEVAR was associated with greater blood loss, longer procedure duration, more frequent staged treatment, lower technical success, and longer postoperative length of stay. In full-cohort multivariable-adjusted analyses, mortality, cerebrovascular events, stroke, myocardial infarction, most access complications, and intensive care unit stay did not differ significantly; however, side-arm branched TEVAR was associated with lower adjusted odds of aortic reintervention before discharge and shorter postoperative length of stay compared with CSB+TEVAR. Through log-rank testing, the overall survival and freedom from aortic reintervention did not differ significantly, whereas freedom from sac enlargement differed significantly. In pairwise propensity score-matched analyses, no significant differences were identified in most perioperative outcomes, although matched sample sizes were limited. CONCLUSIONS: The results demonstrated distinct procedural profiles for CSB+TEVAR, branched TEVAR, and fenestrated TEVAR during zone 2 TEVAR. After adjustment, most perioperative and follow-up outcomes did not differ significantly, supporting the individualized selection of left subclavian artery revascularization strategies based on anatomy, device availability, and institutional expertise.
引用
- Baghbani A, Tanaka A, Keyhani K, et al. Comparative outcomes of open and endovascular left subclavian artery revascularization during zone 2 thoracic endovascular aortic repair. J Vasc Surg. 2026. PMID: 42754184. doi:10.1016/j.jvs.2026.08.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。